Responding to the publication of the report on the Future of Surgery from the Royal College of Surgeons, Dr Mark Slack, Chief Medical Officer at CMR Surgical said:
“This is a much-needed and thorough exploration of the future of surgery which rightly highlights the importance of robotics and the imminent arrival of the next generation of surgical robotic systems.
“We agree with the Commission that minimal access surgery, enabled and assisted by the next generation of surgical robotics, is key to improving surgery for all. The benefits of minimal access surgery (MAS) for patients, including a reduced risk of wound infections and venous thrombosis, decreased pain and less time spent in hospital are clear. Despite clear evidence and NICE guidelines on the benefits of MAS for patients, it is unacceptable that we continue to see over 75% of cases that could benefit from MAS still performed with open surgery. Surgical robotics can unlock the potential of minimal access surgery but uptake of robotics in the NHS to date has been limited due to a number of barriers. Through the introduction of Versius, an affordable and flexible next-generation surgical robotic system, we want to open up the availability of MAS so that patients get better surgery.
“We strongly agree with the recommendation in this report for a robotics strategy at a central level to support the further introduction of robotics in the NHS. Between the NHS, professional bodies and industry we can work together to deliver the benefits of MAS to millions of patients.”
You can read the full report by the Royal College of Surgeons Commission on the Future of Surgery here: https://futureofsurgery.rcseng.ac.uk
About CMR Surgical
CMR Surgical is a British private limited company developing the next-generation universal robotic system, Versius®, for minimal access surgery.
The vision behind CMR Surgical is to make minimal access surgery universally accessible and affordable, transforming the existing market for surgical robotics while also addressing the six million people who still undergo open surgery each year.
Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025.1
CMR Surgical, formed in 2014, has its headquarters in Cambridge, United Kingdom and is backed by an international shareholder base. The Company achieved the registration of its Quality Management System to ISO 13485:2003 by Underwriters Laboratories LLC®(‘UL’), and the status as a UL Registered Firm, in September 2015.
For further information, please visit www.cmrsurgical.com
About Versius, the CMR Surgical robotic system
Designed to meet the complex requirements of laparoscopic surgery, Versius’ compact size fits easily into the existing surgical workflow, while its ergonomic console design allows surgeons to work in a way that reduces physical and mental effort. Intended to be used across a range of surgical specialties, the versatility and portability of Versius, enabled by a unique and patented four-axis wrist joint, expands the potential for higher utilisation. The versatility of the system and compelling commercial model allows healthcare providers to offer the benefits of robotic-assisted procedures in a cost-effective way.